Search results
Results from the WOW.Com Content Network
In December 2022, Solovei announced Putin was being treated with cancer drugs for an unspecified, advanced stage cancer and "the end is already in sight". [13] Several years prior, in 2017, Solovei suggested that Putin might resign due to ill health. [1] Professional opinion concerning Putin's mental health has been expressed: [14]
While Putin’s health had come under scrutiny before his 2022 invasion of Ukraine, its frequent mention in the press is the product of “wishful” thinking, Mr Nixey said. “71 years old is ...
Putin also served as Prime Minister of Russia from 1999 to 2000 [e] and again from 2008 to 2012. [f] [7] He is the longest-serving Russian president since the independence of Russia from the Soviet Union. Putin worked as a KGB foreign intelligence officer for 16 years, rising to the rank of lieutenant colonel. He resigned in 1991 to begin a ...
According to it, the real Putin spends most of his time in a bunker and receives guests at a long table, while meetings with the public are supposedly attended by body doubles. [7] In March 2023, "General SVR" noted that Putin had allegedly not been to Crimea or Mariupol and that a presidential body double had gone there "for a short visit and ...
President Donald Trump has issued a warning to Russian leader Vladimir Putin on his first day in office. As the 47th president settles into his role at the White House, he was asked about the ...
Rumours about the Russian president's supposed blood cancer have been swirling for months. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. [3] [4] Cancer can be difficult to diagnose because its signs and symptoms are often nonspecific, meaning they may be general phenomena that do not point directly to a specific disease process. [5]
A number of countries and companies are working on cancer vaccines. Last year the UK government signed an agreement with Germany-based BioNTech to launch clinical trials providing "personalised ...